Biolife Solutions (BLFS) Gross Profit (2010 - 2026)

Biolife Solutions (BLFS) has 17 years of Gross Profit data on file, last reported at $17.5 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 18.22% year-over-year to $17.5 million in Q1 2026; TTM through Mar 2026 was $58.5 million, a 35.15% increase from a year earlier, with the FY2025 full-year figure at $62.1 million, up 24.0% from the prior year.
• Gross Profit for Q1 2026 stood at $17.5 million, up from -$12.5 million in the prior quarter.
• Over the last five years, Gross Profit for BLFS reached as high as $38.9 million in Q2 2022 and fell as low as -$36.8 million in Q4 2022.
• Historically, Gross Profit has averaged $14.7 million across 5 years, with a median of $21.4 million in 2024.
• On a YoY basis, Gross Profit climbed as much as 220.47% in 2022 and fell as far as 437.42% in 2022.
• Year by year, Gross Profit stood at -$36.8 million in 2022, then climbed by 21.08% to -$29.0 million in 2023, then jumped by 77.0% to -$6.7 million in 2024, then slumped by 86.8% to -$12.5 million in 2025, then surged by 240.19% to $17.5 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $17.5 million in Q1 2026, -$12.5 million in Q4 2025, and $28.1 million in Q3 2025.